Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05775146 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

SBRT of Metastases Following Neo-adjuvant Treatment for Colorectal Cancer With Synchronous Liver Metastases

StatusRecruiting
PhasePhase 2
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Re-verified, no change to tracked fieldsv5
  2. Trial status: Not Yet Recruiting to Recruiting
    • Start date changed from estimate of Sep 30, 2024 to Jun 18, 2024
    • Site details revised
    v4
  3. Start date: Sep 30, 2023 to Sep 30, 2024v3
  4. Start date: Jun 30, 2023 to Sep 30, 2023
    • Secondary endpoints revised (5)
    v2
  5. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The purpose of this study is to prospectively evaluate the feasibility of SBRT for the management of synchronous oligo metastatic liver metastases from colorectal cancers.
Trial Details
NCT Number NCT05775146
Lead Sponsor AHS Cancer Control Alberta
Conditions
(from sponsor)		 Colorectal Cancer, Liver Metastasis Colon Cancer
Related terms Colorectal Neoplasms
Enrollment 24 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov